RK-pulsed autologous antigen-presenting cell therapy (RIKEN/Ambicion/Keio University)
N/A
Report date: 2025/02/01 20:00:06
Base Information
Drug NameRK-pulsed autologous antigen-presenting cell therapy (RIKEN/Ambicion/Keio University)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRiken
China Registration ClassN/A
Develop Information
Active CompaniesRikenAmbicionKeio University
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A